KoreaFilings
Cellemics (KRX: 331920)

Park Jong-gap reports 2,259,634 shares held as co-CEO and major shareholder

insider · spotted Sep 3, 2026, 10:02 AM KST

As co-CEO holding 22.74% of shares, Park's position represents significant concentration of voting control and potential influence over corporate decisions.

View original DART filing ↗

AI-generated summaries of public DART filings. May contain errors — always verify against the original (linked). Not investment advice.